Year archive

Jenscare Scientific Co., Ltd. — 2023 filings

All 58 regulatory filings released by Jenscare Scientific Co., Ltd. (9877) in 2023, sourced directly from the official regulator.

58 Filings

2023 Period

2023 filings (58)

Filing	Released	Lang
VOLUNTARY ANNOUNCEMENT SHARE PURCHASE PURSUANT TO THE H SHARE SCHEME Transaction in Own Shares	2023-12-29	English
DISCLOSEABLE TRANSACTION ENTERED INTO THE EQUITY TRANSFER AGREEMENT Capital/Financing Update	2023-12-21	English
SUPPLEMENTAL ANNOUNCEMENT DISCLOSEABLE TRANSACTION IN RELATION TO THE PROPOSED SALE OF EQUITY INTEREST IN THE TARGET COMPANY Capital/Financing Update	2023-12-20	English
POLL RESULTS OF THE 2023 SECOND EXTRAORDINARY GENERAL MEETING HELD ON DECEMBER 15, 2023 Declaration of Voting Results & Voting Rights Announcements	2023-12-15	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023 Regulatory Filings	2023-12-05	English
(1) PROPOSED GRANTING OF REPURCHASE MANDATE TO REPURCHASE H SHARES; (2) PROPOSED ADOPTION OF THE H SHARE AWARD AND TRUST SCHEME; (3) PROPOSED AUTHORIZATION TO THE BOARD AND/OR THE DELEG Proxy Solicitation & Information Statement	2023-11-28	English
NOTICE OF THE 2023 SECOND EXTRAORDINARY GENERAL MEETING AGM Information	2023-11-28	English
PROXY FORM FOR THE 2023 SECOND EXTRAORDINARY GENERAL MEETING TO BE HELD ON FRIDAY, DECEMBER 15, 2023 Proxy Solicitation & Information Statement	2023-11-28	English
DISCLOSEABLE TRANSACTION PROPOSED SALE OF EQUITY INTEREST IN THE TARGET COMPANY Capital/Financing Update	2023-11-28	English
(1) PROPOSED GRANTING OF REPURCHASE MANDATE TO REPURCHASE H SHARES; (2) PROPOSED ADOPTION OF THE H SHARE AWARD AND TRUST SCHEME; (3) PROPOSED AUTHORIZATION TO THE BOARD AND/OR THE DELEG Capital/Financing Update	2023-11-28	English
VOLUNTARY ANNOUNCEMENT ONE-YEAR RESULTS OF THE CONFIRMATORY CLINICAL TRIAL OF LUX-VALVE RELEASED AT THE PCR LONDON VALVES 2023 Regulatory Filings	2023-11-28	English
SIMULOCK SUCCESSFULLY COMPLETES IMPLANTATION SURGERY FOR THE FIRST CONFIRMATORY CLINICAL TRIAL Regulatory Filings	2023-11-13	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023 Regulatory Filings	2023-11-03	English
VOLUNTARY ANNOUNCEMENT LUX-VALVE PLUS TRAVEL II RESULTS RELEASED AT THE 2023 TCT IN THE U.S. Regulatory Filings	2023-10-31	English
VOLUNTARY ANNOUNCEMENT KEN-VALVE REGISTRATION APPLICATION ENTERS NMPA PRIORITY APPROVAL PROCESS Regulatory Filings	2023-10-30	English
VOLUNTARY ANNOUNCEMENT LUX-VALVE PLUS SUCCESSFULLY COMPLETES A SERIES OF FEE-FOR-SERVICE COMPASSIONATE USE TREATMENTS IN THE ASIA-PACIFIC REGION Regulatory Filings	2023-10-20	English
VOLUNTARY ANNOUNCEMENT RELEASE OF THE RESULTS OF THE MULTICENTER CLINICAL TRIAL OF LUX-VALVE PLUS AT THE 2023 TCT IN THE U.S. Regulatory Filings	2023-10-19	English
VOLUNTARY ANNOUNCEMENT REGISTRATION APPLICATION FOR KEN-VALVE ACCEPTED BY THE NMPA Regulatory Filings	2023-10-11	English
VOLUNTARY ANNOUNCEMENT LUX-VALVE PLUS SELECTED FOR THE EXPERT PANEL SCIENTIFIC ADVICE PILOT Regulatory Filings	2023-10-10	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023 Regulatory Filings	2023-10-06	English
2023 Interim Report Interim / Quarterly Report	2023-09-18	English
VOLUNTARY ANNOUNCEMENT ENROLLED IN FDA TOTAL PRODUCT LIFE CYCLE ADVISORY PROGRAM (TAP) PILOT Regulatory Filings	2023-09-18	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023 Regulatory Filings	2023-09-05	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2023 Interim / Quarterly Report	2023-08-28	English
DATE OF BOARD MEETING Report Publication Announcement	2023-08-16	English
VOLUNTARY ANNOUNCEMENT COMPLETION OF THE FIRST FEE-FOR-SERVICE COMPASSIONATE USE TREATMENT WITH LUX-VALVE PLUS IN THE ASIA-PACIFIC REGION Regulatory Filings	2023-08-07	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023 Regulatory Filings	2023-08-04	English
Articles of Association Governance Information	2023-08-01	English
EARLY FEASIBILITY STUDY OF LUX-VALVE PLUS PRE-SUBMISSION ACCEPTED BY THE FDA Regulatory Filings	2023-07-07	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023 Regulatory Filings	2023-07-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023 Major Shareholding Notification	2023-06-05	English
POLL RESULTS OF THE 2022 ANNUAL GENERAL MEETING HELD ON MAY 31, 2023 Declaration of Voting Results & Voting Rights Announcements	2023-05-31	English
POLL RESULTS OF THE 2023 FIRST EXTRAORDINARY GENERAL MEETING, THE 2023 FIRST CLASS MEETING OF H SHAREHOLDERS AND THE 2023 FIRST CLASS MEETING OF DOMESTIC SHAREHOLDERS AND UNLISTED FOREIGN SHAREHOLDERS Declaration of Voting Results & Voting Rights Announcements	2023-05-16	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2023 Regulatory Filings	2023-05-05	English
PROXY FORM FOR THE 2022 ANNUAL GENERAL MEETING TO BE HELD ON WEDNESDAY, MAY 31, 2023 AGM Information	2023-04-25	English
NOTICE OF 2022 ANNUAL GENERAL MEETING AGM Information	2023-04-25	English
2022 Annual Report Annual Report	2023-04-25	English
(1) 2022 REPORT OF THE BOARD OF DIRECTORS (2) 2022 REPORT OF THE BOARD OF SUPERVISORS (3) 2022 AUDITED FINANCIAL STATEMENTS (4) 2022 ANNUAL REPORT (5) 2022 FINANCIAL ACCOUNTS REPORT (6) 2023 FINANCIAL AGM Information	2023-04-25	English
ARTICLES OF ASSOCIATION Governance Information	2023-04-25	English
PROXY FORM FOR THE 2023 FIRST CLASS MEETING OF H SHAREHOLDERS TO BE HELD ON MONDAY, MAY 15, 2023 Proxy Solicitation & Information Statement	2023-04-20	English
PROXY FORM FOR THE 2023 FIRST CLASS MEETING OF DOMESTIC SHAREHOLDERS AND UNLISTED FOREIGN SHAREHOLDERS TO BE HELD ON MONDAY, MAY 15, 2023 Proxy Solicitation & Information Statement	2023-04-20	English
NOTICE OF THE 2023 FIRST CLASS MEETING OF DOMESTIC SHAREHOLDERS AND UNLISTED FOREIGN SHAREHOLDERS Capital/Financing Update	2023-04-14	English
PROXY FORM FOR THE 2023 FIRST EXTRAORDINARY GENERAL MEETING TO BE HELD ON MONDAY, MAY 15, 2023 Proxy Solicitation & Information Statement	2023-04-14	English
NOTICE OF THE 2023 FIRST EXTRAORDINARY GENERAL MEETING Capital/Financing Update	2023-04-14	English
NOTICE OF THE 2023 FIRST CLASS MEETING OF H SHAREHOLDERS Capital/Financing Update	2023-04-14	English
(1) PROPOSED ISSUE OF A SHARES AND LISTING ON THE STAR MARKET AND OTHER ANCILLARY RESOLUTIONS; (2) PROPOSED AMENDMENTS TO THE ARTICLES PURSUANT TO THE TRIAL MEASURES (3) PROPOSED AMENDMENTS TO TH Proxy Solicitation & Information Statement	2023-04-14	English
(1) PROPOSED ISSUE OF A SHARES AND LISTING ON THE STAR MARKET AND OTHER ANCILLARY RESOLUTIONS; (2) PROPOSED AMENDMENTS TO THE ARTICLES PURSUANT TO THE TRIAL MEASURES; AND (3) PROPOSED AMENDM Capital/Financing Update	2023-04-14	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2023 Regulatory Filings	2023-04-11	English
Terms of Reference of the Remuneration and Appraisal Committee Governance Information	2023-03-28	English
REVISION OF ANNUAL CAPS UNDER THE MASTER LEASE AGREEMENT AND THE MEDICAL DEVICES ACCESSORIES PURCHASE AGREEMENT Regulatory Filings	2023-03-28	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2022 Annual Report	2023-03-28	English
CLOSURE OF REGISTER OF MEMBERS OF H SHARES FOR 2023 FIRST EXTRAORDINARY GENERAL MEETING AND 2023 FIRST CLASS MEETING OF H SHAREHOLDERS Regulatory Filings	2023-03-28	English
DATE OF BOARD MEETING Report Publication Announcement	2023-03-16	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2023 Regulatory Filings	2023-03-06	English
VOLUNTARY ANNOUNCEMENT STRATEGIC COOPERATION AGREEMENT WITH LIFETECH SCIENTIFIC CORPORATION Regulatory Filings	2023-02-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2023 Regulatory Filings	2023-02-06	English
ARTICLES OF ASSOCIATION Governance Information	2023-01-16	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2022 Regulatory Filings	2023-01-05	English